- Stella agrees. Its more showing the path that it takes for new products to be able to be sent out to the masses than the process where is now.
- Stella agrees. Its more showing the path that it takes for new products to be able to be sent out to the masses than the process where is now.
- Demonstrating that doing the pivotal trial and submit to regulatory agencies doesn't mean inclusion in programs.
- Demonstrating that doing the pivotal trial and submit to regulatory agencies doesn't mean inclusion in programs.
- I got in touch with EDCTP authorities to highlight that PZQ and moxi and fdc are all edctp invesments. They are very happy about it.
- I got in touch with EDCTP authorities to highlight that PZQ and moxi and fdc are all edctp invesments. They are very happy about it.
- Maurice: what i gather is present the clinical findings and highlight what the next steps are. Im'
- Maurice: what i gather is present the clinical findings and highlight what the next steps are. Im not in the access program. I just know generalically. They're trying to get aproval in Kenya. I cannot give many specifics but yes about the pivotal trials. The panel can take it from there.
- Stella: Those iinvolved in the access will be in the audience. Look at the path from inception to
borja
2 months ago